Bellevue Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-43,700
| Closed | -$1.17M | – | 226 |
|
|
2019
Q3 | $1.17M | Buy |
+43,700
| New | +$1.17M | 0.02% | 139 |
|
|
2019
Q2 | – | Sell |
-62,300
| Closed | -$2.16M | – | 217 |
|
|
2019
Q1 | $2.16M | Buy |
62,300
+36,650
| +143% | +$1.27M | 0.12% | 103 |
|
|
2018
Q4 | $501K | Sell |
25,650
-1,000
| -4% | -$19.5K | 0.03% | 131 |
|
|
2018
Q3 | $710K | Sell |
26,650
-14,850
| -36% | -$396K | 0.05% | 132 |
|
|
2018
Q2 | $1.57M | Sell |
41,500
-1,200
| -3% | -$45.3K | 0.13% | 99 |
|
|
2018
Q1 | $1.4M | Sell |
42,700
-650
| -1% | -$21.2K | 0.14% | 100 |
|
|
2017
Q4 | $2.11M | Buy |
43,350
+11,850
| +38% | +$577K | 0.22% | 75 |
|
|
2017
Q3 | $1.7M | Sell |
31,500
-4,500
| -13% | -$243K | 0.18% | 89 |
|
|
2017
Q2 | $2.02M | Hold |
36,000
| – | – | 0.24% | 80 |
|
|
2017
Q1 | $1.41M | Hold |
36,000
| – | – | 0.19% | 89 |
|
|
2016
Q4 | $808K | Hold |
36,000
| – | – | 0.17% | 95 |
|
|
2016
Q3 | $818K | Buy |
+36,000
| New | +$818K | 0.15% | 100 |
|